Skip to main content

Table 3 Unadjusted and adjusted rotavirus vaccine effectiveness in preventing hospitalizations due to rotavirus gastroenteritis by vaccine brand and number of doses received

From: Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain

  Confirmed and probable hospitalized rotavirus cases Confirmed hospitalized rotavirus cases
Vaccination status Cases VE (95% CI), % Cases VE (95% CI), %
   Unadjusted Adjusted   Unadjusted Adjusted
Fully vaccinated       
RV1 22 87(81–92) 86(78–91) 20 86(78–91) 84(75–90)
RV5 20 89(82–93) 88(81–92) 12 91(85–95) 91(84–95)
RV1 a 22 87(80–91) 85(77–90) 20 85(77–91) 84(74–90)
RV5 a 19 88(80–92) 87(80–92) 11 91(84–95) 91(83–95)
Partially vaccinated       
RV1 (1 dose) 6 84(65–93) 82(60–92) 3 90(69–97) 89(66–97)
RV5 (2 doses) 6 90(77–95) 89(75–95) 5 89(74–96) 89(73–95)
RV5 (1 dose) 9 83(68–91) 83(66–91) 7 84(65–92) 84(66–92)
Unvaccinated       
  768 - - 616 - -
  1. aChildren fulfilling the product information criteria for timing of vaccination.